 There is disagreement among researchers as to the exact definition of 22q13 deletion syndrome.The Developmental Synaptopathies Consortium defines PMS as being caused by "SHANK3" mutations, a definition that appears to exclude terminal deletions.The requirement to include "SHANK3" in the definition is supported by many but not by those who first described 22q13 deletion syndrome.